1. Home
  2. DSU vs NAGE Comparison

DSU vs NAGE Comparison

Compare DSU & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Debt Strategies Fund Inc.

DSU

Blackrock Debt Strategies Fund Inc.

HOLD

Current Price

$9.80

Market Cap

607.9M

Sector

Finance

ML Signal

HOLD

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$4.63

Market Cap

350.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSU
NAGE
Founded
N/A
1999
Country
United States
United States
Employees
N/A
117
Industry
Finance Companies
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
607.9M
350.8M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
DSU
NAGE
Price
$9.80
$4.63
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.00
AVG Volume (30 Days)
260.2K
942.2K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.51
Revenue Next Year
N/A
$14.58
P/E Ratio
N/A
$21.29
Revenue Growth
N/A
N/A
52 Week Low
$9.31
$4.16
52 Week High
$10.66
$14.66

Technical Indicators

Market Signals
Indicator
DSU
NAGE
Relative Strength Index (RSI) 53.23 48.43
Support Level $9.60 $4.39
Resistance Level $10.34 $5.32
Average True Range (ATR) 0.11 0.16
MACD 0.04 0.05
Stochastic Oscillator 78.21 84.55

Price Performance

Historical Comparison
DSU
NAGE

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a closed-end management investment company. Its primary investment objective is to seek to provide current income by investing in a diversified portfolio of U.S. companies debt instruments, including senior and subordinated corporate loans, both secured and unsecured, which are rated in the lower rating categories of the established rating services or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. The Fund may invest directly in debt instruments or synthetically through the use of derivatives. The Fund's secondary investment objective is to seek to provide capital appreciation.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: